Company profile

Clever Culture Systems

Pathology & Laboratory Diagnostics

Company profile

About Clever Culture Systems

Clever Culture Systems is a leader in microbiology technology driven by artificial intelligence, specializing in automated culture plate reading solutions for pharmaceutical manufacturing and clinical laboratories. The company's flagship product, APAS Independence (Automated Plate Assessment System), is a world-leading in-vitro diagnostic instrument that automates the imaging, analysis, and interpretation of agar culture plates following incubation. Designed by microbiologists for microbiologists, the system uses advanced imaging and sophisticated AI algorithms to identify, interpret, and count microbial growth on culture media, processing up to 200 plates per hour without manual intervention. The technology serves pharmaceutical quality control laboratories for environmental monitoring and clinical microbiology labs for applications including urine screening, infection control, and antimicrobial susceptibility testing. APAS Independence has achieved regulatory clearances from the US FDA, CE Marking under IVDR, MHRA registration in the UK, and ARTG listing in Australia. The system integrates with laboratory information management systems (LIMS) to provide real-time reporting, enhanced data integrity, and complete traceability through digital plate images. The company's technology is scientifically validated and referenced in over 25 publications in leading academic journals, offering laboratories improved efficiency, standardization, and staff satisfaction by automating time-consuming, repetitive culture plate reading tasks.

Company description Clever Culture Systems official website

Primary marketPathology & Laboratory Diagnostics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Clever Culture Systems?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Antimicrobial susceptibility testing
  • Environmental monitoring contamination
  • General infection control
  • MRSA screening
  • Urinary tract infections

Who it serves

  • Clinical microbiology laboratories
  • Hospital laboratories
  • Pharmaceutical manufacturers
  • Quality control laboratories

Deployment & integration

Embedded · On Premise deployment with recorded integration context.

Recorded integration context: LIMS (Laboratory Information Management Systems) - multiple formats.

Geographic context

MarketsAustralia · Europe · Switzerland · United Kingdom · United States
Company sourceOfficial website

Company milestones

Platform expansion

Achieved CE Marking under new IVDR regulations. Multiple regulatory clearances across US, Europe, UK, and Australia.

Partnerships

Recorded partners

  • HSL (Hampton Specialist Laboratory)

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

APAS Independence

AI-powered automated culture plate reading system for microbiology labs

Device · On PremiseCompany source

APAS Independence Analysis Modules - Clinical

AI-enabled software for clinical microbiology plate analysis

Software · EmbeddedCompany source

APAS Independence Analysis Modules - Pharma

AI-enabled software for pharmaceutical environmental monitoring plate analysis

Software · EmbeddedCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

3x faster processing speed

200 plates per hour vs manual handling

Improved data integrity

Reduced human error with digital audit trail

Staff redeployment

MRSA reads managed by one staff member instead of multiple

Faster turnaround time

Real-time reporting to LIMS as plates are processed

HSL (Health Services Laboratories)

MRSA screening automation to redeploy staff to higher-value work

Able to manage MRSA reads using only one staff member, enabling redeployment to developmental projects

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

No active leadership profiles are currently listed.

06 · Company updates

Updates from Clever Culture Systems

Recent articles published on Clever Culture Systems's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Pathology & Laboratory Diagnostics

Companies applying AI to digital pathology, histopathology slide analysis, laboratory diagnostics, or biomarker discovery. Includes AI-powered interpretation of lab test results, at-home diagnostic devices with AI analysis, and platforms that analyze tissue samples or biological specimens to support clinical diagnosis.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon